UMAXIN 5

COMPOSITION:

  • Flunixin Meglumine………………………..........….50mg
  • Phenol…………………….......……………….….....5mg
  • Sodium Formaldehyde Sulfoxylate Dihydrate.…2.5mg
  • Excipients q.s.…………………………………….....1ml

TARGET SPECIES:

Horses, cats, dogs, pigs, goats, sheep, and cattle.

DESCRIPTION:

It is a non-steroid anti-inflammatory (AINE), analgesic and antipyretic.

INDICATIONS:

  • Anti-inflammatory, analgesic and anti-pyretic.
  • Indicated in horses, cattle, goats, sheep, dogs and cats.
  • Powerful painkiller soft tissue including visceral (colic). Use in endotoxemia.
  • Used in inflammation and músculoskeletal pains.
  • Maximum therapeutic effects to 2 hours. Analgesia up to 30 hours.
  • Indicated in mastitis and respiratory infectious processes that occurs with inflammatory symptoms.
  • Also indicated in diarrhea and endotoxic shock.
  • In horses also used after injuries careers or post-surgical.
  • In dogs used in processes of arthritis and spinal disk injuries, although not recommended more than one application.

DOSE AND ROUTE OF ADMINISTRATION:

  • Slow intramuscular or intravenous.
  • Horses: 1.1 mg/kg Intravenously, Orally, Intramuscularly. Do not exceed 3 days.
  • Dogs and cats: 1 mg/kg every 24 hours during a maximum of 3 days/week.
  • Dogs: Also, indicated in ocular inflammatory disorders: 0.5 mg/kg IV, once.
  • Unit dose in cases of bovine neonatal diarrhea.
  • Pigs: Use in pyrexia associated to respiratory diseases 2.2 mg/kg IM once.
  • Cattle, goat, sheep: 1.1 – 2.2 mg/kg every 24 hours during 3 days.

WARNINGS AND PRECAUTIONS:

  • Sale under medical prescription.
  • Do not use with known hypersensitivity animals.

VETERINARY PRODUCT. KEEP OUT REACH OF CHILDREN AND PETS.

WITHRAWAL PERIOD:

  • Meat: 4 days. Milk: 36 hours if used IV (Cattle).
  • Meat: 30 days. Milk: 72 hours if used IM, Subcutaneous (Cattle).
  • Pigs: 12 days.

STORAGE:

Storage in dry and cool places. Protected from direct sunlight. Store between 0° and 30° C.

ADVERSE REACTIONS:

The intra-arterial administration of the product can cause adverse reactions (incoordination, ataxia, muscle weakness), which are brief and rapidly disappear without medication. This route of administration should be avoided.

It should not be taken with other nonsteroidal anti-inflammatory drugs. Nor it must be associated with drugs that produce renal toxicity.

Treatment should not exceed 5 days in any of the species to which it is intended.

PRESENTATIONS:

Bottle 20ml, 50ml and 100ml.

PRESENTATIONS: